openPR Logo
Press release

Cardiac Rehabilitation Market will be Worth US$1,622.9 Million by 2024

09-07-2017 11:48 AM CET | Health & Medicine

Press release from: TMR - Research Reports

Cardiac Rehabilitation Market will be Worth US$1,622.9 Million

In the highly consolidated global market for cardiac rehabilitation, innovations and product costs will be major determinants of success, marks a recent report by Transparency Market Research. The top two companies in the market, Brunswick Corporation and Technogym, had a clear hold on the market’s overall growth prospects, accounting for a combined share of over 50% in 2015. Other leading vendors such as Brunswick Corporation, Johnson health Tech Co., and Amer Sports, in combination with these two companies, accounted for a share of nearly 70% in the global market in the same year.

Rising Global Population of Geriatrics to be Major Driver

The world’s population of people aged more than 60 years is rising at a rapid pace, upping the risk of cardiovascular diseases as aging has a major impact on the body’s cardiovascular system. This factor is also the root cause of the increasing rates of morbidity, disability, mortality, and a substantial rise in the world’s healthcare costs. According to the Institute for Health Metrics and Evaluation, the world’s geriatric population suffered a 55% rise in deaths due to cardiovascular diseases between the period of 1990 and 2013.

View Full Report: http://www.transparencymarketresearch.com/cardiac-rehabilitation-market.html

WHO statistics, on the other hand, highlight another major concern – the high prevalence of cardiovascular diseases and resultant rise in deaths in developing and underdeveloped countries. Low- and middle-income countries in developing and underdeveloped parts of the globe account for a staggering 82% share in the total number of deaths caused due to non-communicable diseases across the world; of these, cardiovascular diseases account for a massive 37% share. Driven with the aim of improving the situation, sustained efforts for preventing and treating cardiovascular diseases undertaken on national and international levels will have a major impact the global cardiac rehabilitation market in the future.

High Product Costs to Constrain Demand for Cardiac Rehabilitation

Being a highly capital- and research-intensive marketplace, cardiac rehabilitation products, quite naturally, carry a high price tag and always carry the risk of being outclassed by newer and most often technologically advanced products in the market. In this highly dynamic market, where the rate of introduction of technologically advanced varieties of product types is immense, the high and rising costs of cardiac rehabilitation products are a major restraints for further expansion. Cost is a major constraint especially for the market’s growth in developing regions such as Asia Pacific and Latin America.

Request to view Sample Report: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=12062

Apart from the factor of cost, low enrolments in cardiac rehabilitation programs and lack of skilled resources providing cardiac rehabilitation services are also major restraints for the global cardiac rehabilitation market. To overcome the challenge of low enrolments, vendors will have to focus more on formulating programs that have flexible schedules and are sensitively priced according to the region of operation. Intervention from government and private educational institutes will be necessary for increasing the number of rehabilitation counsellors on a global front.

The global market for cardiac rehabilitation had a valuation of US$1,010.93 mn in 2015. It will expand at a healthy 5.4% CAGR from 2016 through 2024 and rise to a valuation of US$1,622.9 mn by 2024.

Global Cardiac Rehabilitation Market Report is available @ US$ 5795: http://www.transparencymarketresearch.com/checkout.php?rep_id=12062<ype=S

About TMR

Transparency Market Research (TMR) is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather and analyze information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

US Office Contact

90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com/

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Cardiac Rehabilitation Market will be Worth US$1,622.9 Million by 2024 here

News-ID: 702768 • Views:

More Releases from TMR - Research Reports

Pulmonary Drugs Market is Expected to Reach US$ 28,082.1 Million by the End of 2024
Pulmonary Drugs Market is Expected to Reach US$ 28,082.1 Million by the End of 2 …
According to the research report, the global pulmonary drugs market is expected to be worth US$ 28,082.1 mn by the end of 2024 as compared to US$ 48,039.7 mn in 2015. Analysts calculate that the global market will plummet at a CAGR of -6.3% during the forecast period of 2016 and 2024. The market will thrive as the demand for combination drugs is anticipated to remain on the rise during
North America Ventricular Assist Device Market is rising to a valuation of US$ 1.07 Billion by 2024
North America Ventricular Assist Device Market is rising to a valuation of US$ 1 …
According to TMR, the opportunity in the North America market for VADs, which stood at US$0.4 bn in 2015, is likely to expand at a healthy CAGR of 9.20% between 2016 and 2024 and increase to US$1.07 bn by the end of the forecast period. The destination therapy (DT) segment has been reporting a greater application of VADs than the other two indication segments. It is expected to remain the
Dental Membrane and Bone Graft Substitutes Market to rise to US$ 922.6 Million by 2024
Dental Membrane and Bone Graft Substitutes Market to rise to US$ 922.6 Million b …
Transparency Market Research notes that innovation and expansion into emerging regions have served these companies well in strengthening their hold in the dental membrane and bone graft substitutes market. For instance, Switzerland-based Geistlich Pharma AG - a global manufacturer and supplier of dental products and devices - expanded its operations in Sydney, Australia and New Delhi, India in 2016. The global dental membrane and bone graft substitutes market is expected to
Human Vaccines Market is Estimated to Reach US$ 72.5 Billion by 2024
Human Vaccines Market is Estimated to Reach US$ 72.5 Billion by 2024
The global human vaccines market was valued at US$28.3 bn in 2015 and is estimated to reach US$72.5 bn by 2024, registering an 11.2% CAGR during the forecast period. By age group, pediatric vaccines accounted for a 57.5% share in the global human vaccines market in 2015. Adult vaccines, on the other hand, are expected to expand at a 13.2% CAGR from 2016 to 2024. Based on product, the pneumococcal segment

All 5 Releases


More Releases for Cardiac

Cardiac Monitoring & Cardiac Rhythm Management Device Market
According to a new market research report published by Global Market Estimates, the Global Cardiac Monitoring & Cardiac Rhythm Management Devices Market is expected to grow at a CAGR of 3.88% during the forecast period. The increasing occurrence of dyslipidemia, hypertension, and rising demand for cardiac monitoring & cardiac rhythm management devices to save patients at a huge risk of cardiac arrest. Browse 145 Market Data Tables and 119 Figures spread
Global Cardiac Monitoring & Cardiac Rhythm Management Market Insights, Forecast
Cardiac monitoring (CM) devices help in continuous examination of a patient’s cardiac activity. Cardiac rhythm management (CRM) devices maintain normal cardiac rhythm in patients suffering from rate and rhythm disorders of the heart. These devices play a crucial role in the treatment of serious cardiac disorders, including heart failure, atrial fibrillation, atrial flutter, indications of recent heart attack, coronary ischemia, lack of oxygen supply to cardiac muscles, effects of drugs,
Cardiac Monitoring & Cardiac Rhythm Management Devices Market Stupendous Growth …
Cardiac Monitoring & Cardiac Rhythm Management Devices Market: Snapshot The global cardiac monitoring and cardiac rhythm management devices market is driven by growing incidences of cardiovascular diseases and growing private institutional home care and nursing. The technological advancements in the medical sector have helped develop innovative products and this is furthering the growth of the cardiac monitoring and cardiac rhythm management devices market. The rising treatment costs of cardiac diseases are
Cardiac Monitoring & Cardiac Rhythm Management Devices Market Prophesy in 2025
Cardiac Monitoring & Cardiac Rhythm Management Devices Market: Snapshot The global cardiac monitoring and cardiac rhythm management devices market is driven by growing incidences of cardiovascular diseases and growing private institutional home care and nursing. The technological advancements in the medical sector have helped develop innovative products and this is furthering the growth of the cardiac monitoring and cardiac rhythm management devices market. The rising treatment costs of cardiac diseases are
Cardiac Monitoring & Cardiac Rhythm Management Market Review and Forecast 2025
Crystalmarketresearch.com published “Cardiac Monitoring & Cardiac Rhythm Management Market By Component, Technology, Application, And End User - Global Industry Analysis And Forecast To 2025” from its database. The report reviews top companies involved and enlists all trials pertaining to the company. The cardiac monitoring & cardiac rhythm management market is expected to be worth $XX billion by 2025. The market is largely driven by factors such as rising incidence of cardiovascular
Cardiac Monitoring & Cardiac Rhythm Management Devices Market
Cardiac Monitoring & Cardiac Rhythm Management Devices Market: Snapshot The global cardiac monitoring and cardiac rhythm management devices market is driven by growing incidences of cardiovascular diseases and growing private institutional home care and nursing. The technological advancements in the medical sector have helped develop innovative products and this is furthering the growth of the cardiac monitoring and cardiac rhythm management devices market. The rising treatment costs of cardiac diseases are